
Sign up to save your podcasts
Or


In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
By SpendMend Pharmacy5
3232 ratings
In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641

43,528 Listeners

25,797 Listeners

3,670 Listeners

111,948 Listeners

56,508 Listeners

496 Listeners

14,250 Listeners

6,381 Listeners

23 Listeners

15,472 Listeners

3,461 Listeners

8 Listeners

4 Listeners

7 Listeners

0 Listeners